Cargando…
Nanoparticles as an effective drug delivery system in COVID-19
BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426213/ https://www.ncbi.nlm.nih.gov/pubmed/34649334 http://dx.doi.org/10.1016/j.biopha.2021.112162 |
_version_ | 1783749994883317760 |
---|---|
author | Chowdhury, Neehasri Kumar Deepika Choudhury, Reshma Sonawane, Gaurav Ambadas Mavinamar, Shankar Lyu, Xiaoming Pandey, Ramendra Pati Chang, Chung-Ming |
author_facet | Chowdhury, Neehasri Kumar Deepika Choudhury, Reshma Sonawane, Gaurav Ambadas Mavinamar, Shankar Lyu, Xiaoming Pandey, Ramendra Pati Chang, Chung-Ming |
author_sort | Chowdhury, Neehasri Kumar |
collection | PubMed |
description | BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughing, and pneumonia. In the case of an animal, it causes diarrhea and upper respiratory diseases. Covid-19 transmitted human to human via airborne droplets. First Covid-19 emerged in Wuhan market China and it spread rapidly throughout the World. As we know nanoparticles are a novel drug delivery system. They have various advantageous effects like increasing the efficacy of the drug, safety, etc. In this review, we study about the nanoparticles and summarize how it is effective during drug delivery system in Covid-19. Chitosan is a much focused biopolymeric nanoparticle. It delivers drugs to the specific target site. In a recent health crisis, chitosan nanoparticles are one of the ways to release drugs of Covid-19, and specifically in the lungs of the affected patients. We studied and extracted our data from various research papers, review papers, and some other articles. OBJECTIVE: The main goal is to study the nanoparticles and their future aspects which is an effective drug delivery system in Covid-19. METHODS: The bibliographic search was done through a systematic search. The terms “Nanoparticles”, “Covid-19 ”, “Drug delivery” etc. were used to search the databases/search engines like “Google Scholar”, “NCBI”, “PubMed”, “Science Direct” etc. These databases and search engines used here perform the limited criteria of search to conduct a systematic literature survey for the study and report writing. All the text from the articles and research papers were studied and analyzed. The various articles and research papers were used in writing this report and all of which are mentioned in the reference section of this report. CONCLUSION: Our current studies reveal that nanoparticles may prove very helpful in the delivery of drugs for Covid-19 treatment. Many cases showed that patients, where drugs are delivered with the help of nanoparticles, produced very few side effects. |
format | Online Article Text |
id | pubmed-8426213 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84262132021-09-09 Nanoparticles as an effective drug delivery system in COVID-19 Chowdhury, Neehasri Kumar Deepika Choudhury, Reshma Sonawane, Gaurav Ambadas Mavinamar, Shankar Lyu, Xiaoming Pandey, Ramendra Pati Chang, Chung-Ming Biomed Pharmacother Article BACKGROUND: The global healthcare sector has been dealing with a situation known as a novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is an acronym for Covid-19 (Coronavirus Disease- 2019). It causes a respiratory infection that includes cold, sneezing and coughing, and pneumonia. In the case of an animal, it causes diarrhea and upper respiratory diseases. Covid-19 transmitted human to human via airborne droplets. First Covid-19 emerged in Wuhan market China and it spread rapidly throughout the World. As we know nanoparticles are a novel drug delivery system. They have various advantageous effects like increasing the efficacy of the drug, safety, etc. In this review, we study about the nanoparticles and summarize how it is effective during drug delivery system in Covid-19. Chitosan is a much focused biopolymeric nanoparticle. It delivers drugs to the specific target site. In a recent health crisis, chitosan nanoparticles are one of the ways to release drugs of Covid-19, and specifically in the lungs of the affected patients. We studied and extracted our data from various research papers, review papers, and some other articles. OBJECTIVE: The main goal is to study the nanoparticles and their future aspects which is an effective drug delivery system in Covid-19. METHODS: The bibliographic search was done through a systematic search. The terms “Nanoparticles”, “Covid-19 ”, “Drug delivery” etc. were used to search the databases/search engines like “Google Scholar”, “NCBI”, “PubMed”, “Science Direct” etc. These databases and search engines used here perform the limited criteria of search to conduct a systematic literature survey for the study and report writing. All the text from the articles and research papers were studied and analyzed. The various articles and research papers were used in writing this report and all of which are mentioned in the reference section of this report. CONCLUSION: Our current studies reveal that nanoparticles may prove very helpful in the delivery of drugs for Covid-19 treatment. Many cases showed that patients, where drugs are delivered with the help of nanoparticles, produced very few side effects. The Authors. Published by Elsevier Masson SAS. 2021-11 2021-09-09 /pmc/articles/PMC8426213/ /pubmed/34649334 http://dx.doi.org/10.1016/j.biopha.2021.112162 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Chowdhury, Neehasri Kumar Deepika Choudhury, Reshma Sonawane, Gaurav Ambadas Mavinamar, Shankar Lyu, Xiaoming Pandey, Ramendra Pati Chang, Chung-Ming Nanoparticles as an effective drug delivery system in COVID-19 |
title | Nanoparticles as an effective drug delivery system in COVID-19 |
title_full | Nanoparticles as an effective drug delivery system in COVID-19 |
title_fullStr | Nanoparticles as an effective drug delivery system in COVID-19 |
title_full_unstemmed | Nanoparticles as an effective drug delivery system in COVID-19 |
title_short | Nanoparticles as an effective drug delivery system in COVID-19 |
title_sort | nanoparticles as an effective drug delivery system in covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426213/ https://www.ncbi.nlm.nih.gov/pubmed/34649334 http://dx.doi.org/10.1016/j.biopha.2021.112162 |
work_keys_str_mv | AT chowdhuryneehasrikumar nanoparticlesasaneffectivedrugdeliverysystemincovid19 AT deepika nanoparticlesasaneffectivedrugdeliverysystemincovid19 AT choudhuryreshma nanoparticlesasaneffectivedrugdeliverysystemincovid19 AT sonawanegauravambadas nanoparticlesasaneffectivedrugdeliverysystemincovid19 AT mavinamarshankar nanoparticlesasaneffectivedrugdeliverysystemincovid19 AT lyuxiaoming nanoparticlesasaneffectivedrugdeliverysystemincovid19 AT pandeyramendrapati nanoparticlesasaneffectivedrugdeliverysystemincovid19 AT changchungming nanoparticlesasaneffectivedrugdeliverysystemincovid19 |